We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.30 | 2.50 | 2.40 | 2.40 | 2.40 | 14,156 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.53 | 13.04M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/11/2024 10:46 | Enjoy while it lasts. This will be the next MATD imho. Disastrous. | batiatus | |
14/11/2024 07:52 | No, that's not possible. Buy back 2.00 v 2.20. Will drift today, maybe Monday or Tuesday will be around 2.10 | atmysignal | |
14/11/2024 07:29 | POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. | m_night10 | |
14/11/2024 07:14 | Separately. genedrive plc @genedriveplc We had a great first day at MEDICA... Gino Miele, Patrick Breen, Claire Newton, Jonathan Dale are on the stand and ready to meet you. Bring on Day 2! | hazl | |
14/11/2024 07:14 | Am I alone in following FDA in the US on x? A good way to keep up with what's going on generally . imo | hazl | |
13/11/2024 18:11 | the NHS has a massive reputation in the medical world, and their experience with our product will be filtering around the world. | petersmith6 | |
13/11/2024 16:23 | Told you it was a pump and dump. Batiatus is right once again. I hope no one was naive enough to get sucked in. (But anyone did have themselves to blame) This is a no profit company, just pure speculation. There is not even a debate about it. If they have concrete news then just release it. The companies fundamentals have not changed one bit. Monthly cash burn is still £400-600K. There have been no other sales besides the £100K 9 months ago. The directors cannot expect to sit around all day taking a salary without providing any value to shareholders. They need to prove the kits can sell and start making some profit. As things stand, it's just a weeks after weeks without sales, only cash burn. The only thing that is coming is a fundraise. (G)enuinely (D)on't (R)ecommend | batiatus | |
13/11/2024 15:53 | The question is, did the foreskin Batty make any money today?I did! | premium beeks | |
13/11/2024 15:22 | signal - thanks for the advice. I've sold the lot and will get back in again at 5p!!!!!!! | eggbaconandbubble | |
13/11/2024 15:07 | Pity the Dow doesn't look so healthy out in the US. Seems to have stifled momentum. However news usually revives. Come on GDR an RNS please! | hazl | |
13/11/2024 14:38 | POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 155p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. | m_night10 | |
13/11/2024 13:51 | So just as an observation for anyone new to this game, if you are wanting to buy a stock, sometimes lunch time is a good time. People look at stocks over their lunch hour, especially if they work and possibly take profits. It can soften the price. But I am not encouraging people to buy anything just trying to pass on a few things I have noticed over the years. When there are announcements people often rush in first thing, not neccessarily the best time to buy. IMO | hazl | |
13/11/2024 11:18 | You don't get an introduction to a clinic and leaflets given out to visitors unless they are seious about a test I'm sure. The beauty of it will be if it's rolled out in the NHS everywhere. Then onto the US! | hazl | |
13/11/2024 11:15 | There's often a lull on a rising share at this sort of time in my experience. Lunch time also. But after 3pm it tends to remain in the direction it is headed. IMO | hazl | |
13/11/2024 11:09 | Take profit fellas.Going back to 2.10 v 2.20 | atmysignal | |
13/11/2024 10:37 | Would like to see it make an assault to 4's for consolidation, before the next push north from there, GLA | lawson27 | |
13/11/2024 10:13 | Back to big volume again. | premium beeks | |
13/11/2024 08:54 | A no profit company, just pure speculation. There is not even a debate here. If they have concrete news then just release it. The companies fundamentals have not changed one bit. Monthly cash burn is still £400-600K. There have been no other sales besides the £100K 9 months ago. The directors cannot expect to sit around all day taking a salary without providing any value to shareholders. They need to prove the kits can sell and start making some profit. As things stand, it's just a weeks after weeks without sales, only cash burn. The only thing that is coming is a fundraise. (G)enuinely (D)on't (R)ecommend | batiatus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions